Share on LinkedInShare on LinkedIn

ARTICLE · 08 DECEMBER 2017

ACCC Claims Against Medibank For Misleading Or Deceptive Conduct And Unconscionable Conduct

Jones Day
Jones Day
Contributor
Jones Day

Jones Day

Jones Day is a global law firm with more than 2,400 lawyers in 40 offices across five continents....

View firm profile
Explore more from Jones Day

On 20 September 2017 the Australian Competition and Consumer Commission (ACCC) appealed a Federal Court judgment that considered the lawfulness of a change to Medibank Private Limited's ("Medibank") insurance coverage of inpatient diagnostic treatment. The ACCC has appealed the first instance decision rejecting the ACCC's claims that Medibank had engaged in misleading or deceptive conduct and unconscionable conduct.

AustraliaInsurance

Summary

On 20 September 2017 the Australian Competition and Consumer Commission (ACCC) appealed a Federal Court judgment that considered the lawfulness of a change to Medibank Private Limited's ("Medibank") insurance coverage of inpatient diagnostic treatment. The ACCC has appealed the first instance decision rejecting the ACCC's claims that Medibank had engaged in misleading or deceptive conduct and unconscionable conduct.

Background Facts

Australia's national health scheme, Medicare, provides subsidised access to prescribed medical services. The Medicare Benefits Schedule ("MBS") lists the medical services to which the scheme applies, and the prescribed fees payable on those medical services (known as schedule fees).

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from